Search

Showing total 18 results
Start Over Topic immune response Language english Journal plus company updates
18 results

1. Nature Scientific Reports has published a peer reviewed paper showing important immune response benefits associated with AOBiome's B244 Ammonia Oxidizing Bacteria drug therapy

Subjects
Bacteria, Atopic dermatitis -- Drug therapy, Immune response, Ammonia, General interest, News, opinion and commentary
Abstract

CAMBRIDGE: AOBiome has issued the following press release: AOBiome Therapeutics, Inc. ('AOBiome'), a leading clinical-stage microbiome company focusing on inflammatory conditions, announced new findings indicating a link between Ammonia Oxidizing [...]

Published
2021

2. EnGeneIC Announces Publication in Cancer Cell of a Scientific Paper Highlighting the Ability of EDV Nanocells to Mount Dual Assault on Cancer Cells

Subjects
Cancer treatment -- Health aspects, Cancer -- Health aspects, Immunotherapy -- Health aspects, Cancer cells, Technology, Immune response, Tumors, General interest, News, opinion and commentary
Abstract

NEW YORK: EnGeneIC Limited has issued the following press release: EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its proprietary EDV nanocell platform for targeted cyto-immunotherapy in cancer, today announced that [...]

Published
2020

3. AgeX Therapeutics and Juvenescence Publish Paper on Engineering Strategies for Universal Cells and Provide in Vivo Observation on Immunotolerance UniverCyteTM Technology Platform

Subjects
HLA antigens, Antigens, Proteins, Technology, Immune response, Biotechnology, Biotechnology industries, General interest, News, opinion and commentary
Abstract

ALAMEDA: AgeX Therapeutics, Inc. has issued the following press release: AgeX Therapeutics, Inc. ('AgeX'; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, and Juvenescence, a [...]

Published
2019

4. SINOVAC advertises positive data for the CoronaVac(r) Booster Shots, strong adult and the elderly immune responses

Subjects
Sinovac Biotech Ltd., Biological products industry, Medical research, Medicine, Experimental, Advertising, Immune response, Adults, Vaccines, General interest, News, opinion and commentary
Abstract

BEIJING: SINOVAC Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today the publication of two papers. The publications detail findings from clinical studies on the immunogenicity, safety, [...]

Published
2021

5. AIVITA Biomedical Publishes Study Comparing Immune Responses and Associated Survivals Induced by Dendritic and Tumor Cell Vaccines

Subjects
Cancer vaccines, Tumors, Immunotherapy, Dendritic cells, Immune response, Vaccines, Clinical trials, Biotechnology industries, General interest, News, opinion and commentary
Abstract

IRVINE: AIVITA Biomedical, Inc. has issued the following press release: AIVITA Biomedical, Inc., a biotechnology company specializing in innovative cell therapy applications, announced today the publication of a paper titled, [...]

Published
2020

6. Peer Reviewed Scientific Publications Highlight TG4010's Ability to Induce Broad CD8+ Responses and its Synergistic Effects in Combination with Immune Checkpoint Inhibitors

Subjects
Vaccines, Chemotherapy, Immunotherapy, Immune response, Non-small cell lung cancer, General interest, News, opinion and commentary
Abstract

Cambridge, MA: Transgene has issued the following news release: Transgene (Euronext Paris: TNG), a biotech company that designs and develops viral-based immunotherapies, recently published two papers supporting the efficacy and [...]

Published
2017

7. Transgene: Peer Reviewed Scientific Publications Highlight TG4010's Ability to Induce Broad CD8+ Responses and its Synergistic Effects in Combination with Immune Checkpoint Inhibitors

Subjects
Vaccines, Immunotherapy, Immune response, Non-small cell lung cancer, General interest, News, opinion and commentary
Abstract

Amsterdam: TRANSGENE has issued the following news release: Transgene (Paris:TNG), a biotech company that designs and develops viral-based immunotherapies, recently published two papers supporting the efficacy and mechanism of action [...]

Published
2017

9. PDS Biotech Announces the Publication of PDS0301 Study Linking Induced Changes in Immune Responses with Clinical Outcomes in International Immunopharmacology Journal

Subjects
Medical research, Medicine, Experimental, Biotechnology, Biotechnology industry, Immune response, Immunotherapy, General interest, News, opinion and commentary
Abstract

FLORHAM PARK, N.J: PDS Biotechnology Corporation has issued the following news release: PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer [...]

Published
2023

10. Provention Bio and Vactech Announce Publication of Proof-of-Concept Data for a Preclinical Prototype of Coxsackievirus B Vaccine

Subjects
Vaccines, Coxsackievirus infections, Infection, Intelligence gathering, Immune response, Biotechnology industries, Diseases, General interest, News, opinion and commentary
Abstract

OLDWICK: Provention Bio, Inc. has issued the following press release: Provention Bio, Inc. (Nasdaq: PRVB), a clinical-stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease and its licensor, Vactech [...]

Published
2020

11. Advaita Bioinformatics and Henry Ford Health System Discover that a Well-Known Drug Helps Prevent Worst COVID-19 Outcomes

Subjects
Computational biology, Drugs, Health care industry, Steroids (Organic compounds), Glucocorticoids, Prednisone, Immune response, Dexamethasone, Clinical trials, Methylprednisolone, Health care industry, General interest, News, opinion and commentary
Abstract

ANN ARBOR, Mich: Advaita Bioinformatics has issued the following news release: Advaita Bioinformatics, the leader in interpretation of high-throughput biomedical data, announced today that they identified a generic drug with [...]

Published
2020

12. Phosplatin Therapeutics Announces Publication in OncoImmunology

Subjects
Cell death, Cancer cells, Cancer treatment, Immune response, Pharmaceutical industry, General interest, News, opinion and commentary
Abstract

NEW YORK: Phosplatin Therapeutics has issued the following press release: Phosplatin Therapeutics LLC, a clinical stage pharmaceutical company focused on oncology drug development, announced its publication in OncoImmunology of in [...]

Published
2020

13. AgeX Therapeutics Enters Research Collaboration With Japanese Biopharma Company to Generate Hypoimmunogenic Cells

Subjects
Stem cells, HLA antigens, Biological products industry -- Research agreements, Stem cell research, Technology, Immune response, Biotechnology industries, General interest, News, opinion and commentary
Abstract

ALAMEDA: AgeX Therapeutics, Inc. has issued the following press release: AgeX Therapeutics, Inc. ('AgeX'; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today a [...]

Published
2020

14. Tizona Announces Publication in Cancer Discovery Highlighting the Important Role of CD39 and Extracellular ATP in Inflammasome-driven Anti-Tumor Immunity

Subjects
Cancer, Immunotherapy, T cells, Cancer treatment, Electronic periodicals, Antibodies, Immune response, Tumors, Enzymes, General interest, News, opinion and commentary
Abstract

SOUTH SAN FRANCISCO: Tizona Therapeutics, Inc. has issued the following press release: Tizona Therapeutics, Inc., a clinical stage, privately held company developing first-in-class cancer immunotherapies, announced today the online publication [...]

Published
2019

15. Publication in Human Vaccines & Immunotherapeutics Illustrates the Advantages of Hexavalent CD40 Agonists in Targeting CD40 in Immuno-Oncology

Subjects
Vaccines, Antigens, Endothelium, Therapeutics, Immune response, Tumors, General interest, News, opinion and commentary
Abstract

HEIDELBERG: Apogenix has issued the following press release: Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today that a new publication in Human Vaccines & Immunotherapeutics highlights the [...]

Published
2019

16. Elicio Therapeutics Co-founder, Darrell Irvine, Co-authors Research Published in Science Demonstrating Novel AMP-CAR-T Approach to Enhance CAR-T Function in Solid Tumor Cancers

Subjects
Cancer -- Care and treatment, T cells, Automobiles, Cancer treatment, Cancer research, Immune response, Tumors, General interest, News, opinion and commentary, Massachusetts Institute of Technology
Abstract

CAMBRIDGE: Elicio Therapeutics has issued the following press release: Elicio Therapeutics, a next generation immuno-oncology company, engineering therapies for cancer killing immune responses, today announced that studies of its Amphiphile [...]

Published
2019

17. Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial

Subjects
Clinical trials -- Health aspects, Vaccines -- Product development -- Planning -- Health aspects, Lassa fever -- Prevention -- Health aspects, International cooperation -- Health aspects, DNA, Immune response, Infection, Company business planning, General interest, News, opinion and commentary
Abstract

PLYMOUTH MEETING: Inovio Pharmaceuticals, Inc. has issued the following news release: Inovio Pharmaceuticals, Inc. (NASDAQ: INO), together with CEPI, today announced it has dosed subjects in a Phase 1, first-in-human [...]

Published
2019

18. Moderna Announces Publication of Phase 1 Data for mRNA Vaccines Against Two Potential Pandemic Influenza Strains

Subjects
Therapeutics -- Product development, Influenza viruses, Influenza vaccines -- Product development, Clinical trials, Epidemics, Messenger RNA, Medical research, Influenza, Biotechnology industries, Vaccines, Immune response, RNA, General interest, News, opinion and commentary
Abstract

CAMBRIDGE: Moderna, Inc. has issued the following press release: Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation [...]

Published
2019